|
ZNF507 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.023400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.371200E-01 |
| Normal-vs-Stage2 |
6.739600E-01 |
| Normal-vs-Stage3 |
7.528400E-01 |
| Normal-vs-Stage4 |
9.391800E-01 |
| Stage1-vs-Stage2 |
3.678200E-01 |
| Stage1-vs-Stage3 |
7.970000E-01 |
| Stage1-vs-Stage4 |
7.740400E-01 |
| Stage2-vs-Stage3 |
5.649000E-01 |
| Stage2-vs-Stage4 |
7.400400E-01 |
| Stage3-vs-Stage4 |
9.093800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.967600E-01 |
| Normal-vs-AfricanAmerican |
5.988000E-01 |
| Normal-vs-Asian |
3.408400E-02 |
| Caucasian-vs-AfricanAmerican |
7.657400E-01 |
| Caucasian-vs-Asian |
8.695400E-03 |
| AfricanAmerican-vs-Asian |
3.323600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.824800E-01 |
| Normal-vs-Female |
8.643600E-02 |
| Male-vs-Female |
8.775300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.716400E-01 |
| Normal-vs-Extreme_Weight |
6.755600E-02 |
| Normal-vs-Obese |
3.630000E-01 |
| Normal-vs-Extreme_Obese |
1.483360E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.902800E-01 |
| Normal_Weight-vs-Obese |
2.435000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.747800E-01 |
| Extreme_Weight-vs-Obese |
2.424000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.535800E-01 |
| Obese-vs-Extreme_Obese |
2.419400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.694400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.564200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.691900E-02 |
| Normal-vs-Age(81-100Yrs) |
6.117900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.450200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.601970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.462400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.218100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.803700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.956400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.944400E-01 |
| Normal-VS-Type2 PRCC |
2.123800E-02 |
| Normal-VS-KIRP CIMP |
2.945200E-01 |
| Normal-VS-Unclassified PRCC |
9.166600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.096300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.058400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.715800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.293600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.013640E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.109600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.430100E-02 |
| Normal-vs-N1 |
1.294360E-01 |
| Normal-vs-N2 |
1.813970E-01 |
| N0-vs-N1 |
1.589770E-02 |
| N0-vs-N2 |
9.375400E-01 |
| N1-vs-N2 |
2.769200E-01 |
|
|
